Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Changyuan Guo"'
Autor:
Xuemin Xue, Lei Guo, Changyuan Guo, Liwei Xu, Lin Li, Lin Yang, Xin Wang, Wei Rao, Pei Yuan, Jiali Mu, Jiangtao Li, Bingning Wang, Quan Zhou, Weicheng Xue, Fei Ma, Wenjing Yang, Jianming Ying
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background In 2022, our team launched the pioneering national proficiency testing (PT) scheme for the pathological diagnosis of breast cancer, rapidly establishing its credibility throughout China. Aiming to continuously monitor and improve
Externí odkaz:
https://doaj.org/article/ae6289b73f00456eb18134b71079b5a7
Autor:
Waruiru Mburu, Changyuan Guo, Yuan Tian, Hela Koka, Sheng Fu, Ning Lu, Erni Li, Jing Li, Renata Cora, Ariane Chan, Jennifer L. Guida, Hyuna Sung, Gretchen L. Gierach, Mustapha Abubakar, Kai Yu, Xiaohong R. Yang
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Background Higher mammographic density (MD), a radiological measure of the proportion of fibroglandular tissue in the breast, and lower terminal duct lobular unit (TDLU) involution, a histological measure of the amount of epithelial tissue i
Externí odkaz:
https://doaj.org/article/da2d57df18654fb99e53fd1aa7049e16
Autor:
Liyan Xue, Yuan Li, Lili Jiang, Chao Liu, Na Cheng, Changyuan Guo, Yan Jin, Ping Zhou, Xuemin Xue, Yue Wang, Weiya Wang, Yanhui Liu, Jianming Ying
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 2, Pp 162-168 (2024)
Background: The prediction of response to immunotherapy mostly depends on the programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) status, and the 22C3 pharmDx assay has been approved in esophageal squamous cell carcinoma (ESCC). However, the
Externí odkaz:
https://doaj.org/article/c05ddd10e3504c71a2ec3c4f4d547b9d
Autor:
Xuemin Xue, Lei Guo, Changyuan Guo, Lin Li, Lin Yang, Xin Wang, Wei Rao, Pei Yuan, Jiali Mu, Jiangtao Li, Bingning Wang, Quan Zhou, Wentao Yang, Yueping Liu, Weicheng Xue, Rujing Jia, Wenjing Yang, Jianming Ying
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Aim Pathologists are currently supposed to be aware of both domestic and international guidelines for breast cancer diagnosis, but it is unclear how successfully these guidelines have been integrated into routine clinical practice in China.
Externí odkaz:
https://doaj.org/article/6078bc17c7ef4c798894bcd4920deed5
Autor:
Xiaolei Pei, Li Liu, Jieru Wang, Changyuan Guo, Qingqing Li, Jia Li, Qian Ren, Runzhi Ma, Yi Zheng, Yan Zhang, Danfeng Zheng, Pingzhang Wang, Ping Jiang, Xiaoming Feng, Erlie Jiang, Ying Wang, Sizhou Feng
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract In pneumonia, the deficient or delayed pathogen clearance can lead to pathogen proliferation and subsequent overactive immune responses, inducing acute lung injury (ALI). While screening human genome coding genes using our peripheral blood c
Externí odkaz:
https://doaj.org/article/bcb23164d4a045b788d408d3cf999d01
Autor:
Fengzhu Guo, Jialu Ma, Cong Li, Shuning Liu, Weizheng Wu, Chunxiao Li, Jiani Wang, Jinsong Wang, Zhijun Li, Jingtong Zhai, Fangzhou Sun, Yantong Zhou, Changyuan Guo, Haili Qian, Binghe Xu
Publikováno v:
Cell Death and Disease, Vol 14, Iss 4, Pp 1-14 (2023)
Abstract Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast neoplasms with a higher risk of recurrence and metastasis than non-TNBC. Nevertheless, the factors responsible for the differences in the malignant behavior betwee
Externí odkaz:
https://doaj.org/article/74ce9dd7595f45baaeb8c1e42c5c8a30
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesTo analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS).Materials and methodsB
Externí odkaz:
https://doaj.org/article/f4b17d614cc84d2598429d6ce27e3152
Autor:
Jiaxiang Liu, Shuangtao Zhao, Chenxuan Yang, Li Ma, Qixi Wu, Xiangzhi Meng, Bo Zheng, Changyuan Guo, Kexin Feng, Qingyao Shang, Jiaqi Liu, Jie Wang, Jingbo Zhang, Guangyu Shan, Bing Xu, Yueping Liu, Jianming Ying, Xin Wang, Xiang Wang, Xiuyuan Hao, Rongman Jia
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 2, Pp 184-193 (2023)
Abstract. Background:. Breast cancer patients who are positive for hormone receptor typically exhibit a favorable prognosis. It is controversial whether chemotherapy is necessary for them after surgery. Our study aimed to establish a multigene model
Externí odkaz:
https://doaj.org/article/ccc97740b5bb41178e302ff479acc8bb
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Although neoadjuvant anti-PD-1 immunotherapies have shown good efficacy in non-small cell lung cancer (NSCLC) patients, there is still a lack of effective predictive markers. We aimed to develop a pretreatment histologic scoring s
Externí odkaz:
https://doaj.org/article/5a5e0ebcc81442bc8a091e1718106800
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Tumor-to-tumor metastasis is a rare phenomenon. Although renal cell carcinoma is the most common recipient tumor, metastatic lobular breast carcinoma to clear cell renal cell carcinoma is even rarer, with only one case reported to date. We present a
Externí odkaz:
https://doaj.org/article/342cb10ac6cd4c79a3bc3a2c7af3e814